Renal Cell Carcinoma: Diagnosis and Management

Area of Science:

• Urology
• Oncology
• Radiology

Background:

• Kidney cancer is a leading cancer in the US, with renal cell carcinoma accounting for 90% of cases.
• Incidence is higher in men, particularly black men.
• Renal masses are often incidentally discovered during computed tomography scans.

Purpose of the Study:

• To outline the detection, diagnosis, and management of kidney cancer.
• To highlight risk factors and prognostic indicators.
• To inform family physicians about kidney cancer awareness and risk reduction.

Main Methods:

• Review of diagnostic imaging techniques, emphasizing contrast-enhanced, triple-phase computed tomography for renal masses.
• Discussion of various treatment modalities, including surveillance, surgery, ablation, and systemic therapies.
• Identification of risk factors such as hypertension, tobacco use, and familial syndromes.

Main Results:

• Contrast-enhanced, triple-phase computed tomography is optimal for detecting cystic or solid renal masses.
• Hematuria is a critical warning sign requiring prompt evaluation.
• New therapies have improved outcomes for metastatic kidney cancer.

Conclusions:

• Early detection and appropriate management are crucial for kidney cancer patients.
• Family physicians play a vital role in recognizing risk factors and promoting preventative measures.
• Prognosis is influenced by functional status and metastasis, but recent advancements offer hope.